AstraZeneca PLC is 143.1x more valuable than NEKTAR THERAPEUTICS by market capitalization ($286.27 B vs $2.00 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NKTR | AZN |
|---|---|---|
| Market cap | $2.00 B | $286.27 B |
| US-listed rank | #2107 | #47 |
| Revenue (latest FY) | $55.23M | - |
| Net income (latest FY) | -$164.00M | - |
| Net margin | -296.9% | - |
| SEC filings | 1,949 | 1,004 |
AstraZeneca PLC is 143.1x more valuable than NEKTAR THERAPEUTICS by market capitalization ($286.27 B vs $2.00 B).
Full pages: NEKTAR THERAPEUTICS and AstraZeneca PLC, or browse the full rankings.